Author:
Oki E.,Murata A.,Yoshida K.,Maeda K.,Ikejiri K.,Munemoto Y.,Sasaki K.,Matsuda C.,Kotake M.,Suenaga T.,Matsuda H.,Emi Y.,Kakeji Y.,Baba H.,Hamada C.,Saji S.,Maehara Y.
Funder
Taiho Pharmaceutical Co. Ltd
Reference18 articles.
1. Colorectal cancer statistics, 2014;Siegel;CA Cancer J Clin,2014
2. Progress in the PROSPECT trial: precision treatment for rectal cancer?;Weiser;Bull Am Coll Surg,2015
3. Introduction and benefit of pelvic sidewall dissection for colorectal cancer;Sugihara;Dis Colon Rectum,2006
4. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial;Hong;Lancet Oncol,2014
5. Final results of randomized trials by the National Surgical Adjuvant Study of Colorectal Cancer (NSAS-CC);Hamaguchi;Cancer Chemother Pharmacol,2011
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献